Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Yumanity Cuts 60% Of Its Workforce, Explores Strategic Alternatives

Yumanity Therapeutics Inc (NASDAQ:YMTX) is exploring strategic alternatives. The Company has engaged H.C. Wainwright as its exclusive financial advisor to assist in this process.

  • In addition, the Board of Directors has approved a strategic restructuring to preserve capital. 
  • As part of the restructuring, the Company anticipates eliminating approximately 60% of its workforce, to be completed by April, among other actions to reduce cash burn while the Company explores strategic alternatives. 
  • Related: Yumanity Shares Fall On FDA Hold On Multidose Trials In Parkinson's Disease.
  • The Company also expects to incur a non-recurring charge of approximately $0.4 million in Q1 FY22 related to the restructuring.
  • Price Action: YMTX shares are down 13.80% at $1.53 during the market session on the last check Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.